Michael Lynch

Michael Lynch, CPA, MBA, is the Executive Director of Oncology Market Access at Bayer Pharmaceuticals, where they lead the US Market Access strategy for oncology products. With twenty years of experience and over fifteen years in the pharmaceutical industry, Michael has a robust background in Market Access, Strategic Analytics, and P&L management. Previously, they held various leadership roles at Bayer, including Director of Customer Strategy and Director of Strategic Analytics, achieving significant results such as the successful launch of eight products across multiple therapeutic areas. Michael holds a Master's in Business Administration from Rutgers Business School and a Bachelor's degree in Accounting from Widener University.